Chad M. Cohen - 22 Dec 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Chief Financial Officer
Signature
/s/ Chad Cohen by Eric Billings, Attorney-in-Fact
Issuer symbol
ADPT
Transactions as of
22 Dec 2021
Net transactions value
-$227,300
Form type
4
Filing time
23 Dec 2021, 20:00:16 UTC
Previous filing
07 Dec 2021
Next filing
25 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $72,700 +10,000 +46% $7.27 31,604 22 Dec 2021 Direct F1
transaction ADPT Common Stock Sale $300,000 -10,000 -32% $30.00 21,604 22 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -10,000 -11% $0.000000 80,000 22 Dec 2021 Common Stock 10,000 $7.27 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
F2 The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.